Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: Keytruda


Reuters rehashes Merck announcement on Keytruda trial for esophageal cancer


Immunotherapy’s ‘new era:’ LA Times story overlooks the risks and overstates trial results


Keytruda for bladder cancer: No independent scrutiny of Merck-reported results


Reuters’ ‘New day in lung cancer’ presents overly rosy picture of Keytruda

1 6/22/2016

NBC News takes level-headed approach covering ‘Jimmy Carter drug’ for lung cancer


Except for presidential anecdote, NBC story on new melanoma drug was well-balanced

5 10/28/2015

News release-based story on cancer drug lacks most of what readers need


Keytruda and colon cancer: coverage of benefits not balanced with harms and cost info